Azelastine Dosing Recommendations
For azelastine nasal spray 0.1%, the recommended dosage is 1-2 sprays per nostril twice daily for adults and children ≥5 years old; for azelastine ophthalmic solution 0.05%, the dosage is 1 drop per eye twice daily for adults and children ≥3 years old.
Nasal Spray Formulations
Azelastine 0.1% Nasal Spray
Adults and Children ≥12 years:
- Standard dose: 2 sprays per nostril twice daily 1
- Alternative dose: 1 spray per nostril twice daily (better tolerated with similar efficacy) 1, 2
Children 5-11 years:
- Recommended dose: 1 spray per nostril twice daily 1
- Safety and efficacy established in controlled trials of 176 patients aged 5-12 years treated for up to 6 weeks 1
- Not approved for children <5 years 1
Azelastine 0.15% Nasal Spray
Adults and Children ≥12 years:
- Dose: 2 sprays per nostril twice daily
- Provides faster onset of action (within 30 minutes) and slightly greater symptom reduction compared to 0.1% formulation 3, 4
Clinical Considerations
Efficacy Profile
The 1-spray per nostril twice daily regimen demonstrates:
- Significantly improved tolerability: bitter taste reduced from 19.7% to 8.3%, somnolence from 11.5% to 0.4% 2
- Maintained clinical efficacy comparable to the 2-spray regimen 2
- This makes the lower dose preferable for initial therapy in most patients
Combination Therapy
When used with intranasal corticosteroids for moderate-to-severe seasonal allergic rhinitis in patients ≥12 years:
- Azelastine 548 mcg daily (as part of combination spray) or 1100 mcg daily (separate sprays) combined with fluticasone propionate 200 mcg provides superior symptom control compared to monotherapy 5
- This represents approximately 2 sprays per nostril twice daily dosing
Common Pitfalls
Dosing technique: Bitter taste (the most common adverse event) is often associated with incorrect administration technique 6. Proper technique includes:
- Avoid tilting head backward
- Aim spray away from nasal septum
- Avoid sniffing deeply immediately after administration
Age restrictions: Do not prescribe for children <5 years as safety and efficacy have not been established 1
Pregnancy: Category C - use only if potential benefit justifies potential risk 1
Ophthalmic Formulation
While the evidence provided focuses on nasal formulations, azelastine ophthalmic solution 0.05% is typically dosed as 1 drop per affected eye twice daily for adults and children ≥3 years based on standard FDA labeling for allergic conjunctivitis 7.